| Partial Spearman correlations for variables with <30% outside the LOD | % <LOD for one or both samples | Rate of sample 2 <LOD where sample 1 <LOD | ||
---|---|---|---|---|---|
n | Partial correlation, 95% CI | p value | |||
Cytokines | |||||
 IL-1A | 26 | .33 (−.09–.64) | .11 | 16 | 1/5 (20%) |
 IL-IRA |  |  |  | 87 | 21/25 (84%) |
 IL-1B |  |  |  | 87 | 23/27 (85%) |
 IL-2 |  |  |  | 84 | 20/23 (87%) |
 sIL-2RA |  |  |  | 65 | 15/17 (88%) |
 IL-3 |  |  |  | 52 | 15/15 (100%) |
 IL-4 |  |  |  | 97 | 29/29 (100%) |
 IL-5 | 28 | .85 (.68–.93) | <.0001 | 10 | 1/3 (33%) |
 IL-6 |  |  |  | 94 | 28/29 (97%) |
 IL-7 |  |  |  | 71 | 19/19 (100%) |
 IL-9 | 31 | .82 (.63–.91) | <.0001 | 0 | na |
 IL-10 |  |  |  | 35 | 8/11 (73%) |
 IL-12p40 |  |  |  | 61 | 13/19 (68%) |
 IL-12p70 |  |  |  | 94 | 24/25 (96%) |
 IL-13 |  |  |  | 100 | 30/31 (97%) |
 IL-15 | 31 | .80 (.61–.90) | <.0001 | 0 | na |
 IL-17 |  |  |  | 94 | 27/28 (96%) |
 IFNα2 | 30 | .74 (.50–.87) | <.0001 | 3 | 0/1 (0%) |
 IFNγ |  |  |  | 68 | 16/18 (89%) |
 TNFα | 31 | .62 (.32–.80) | .004 | 0 | na |
 TNFβ |  |  |  | 65 | 12/16 (75%) |
 TGFα | 31 | .84 (.67–.92) | <.0001 | 0 | na |
Growth factors | |||||
 EGF |  |  |  | 100 | 31/31 (100%) |
 G-CSF | 31 | .53 (.19–.75) | .003 | 0 | na |
 GM-CSF | 31 | .72 (.48–.86) | <.0001 | 0 | na |
 VEGF |  |  |  | 97 | 26/29 (90%) |
 FGF-2 |  |  |  | 74 | 17/21 (81%) |
 FLT-3L | 31 | .82 (.64–.91) | <.0001 | 0 | na |
 sCD40L | 27 | .63 (.30–.82) | .0008 | 13 | 1/4 (25%) |
Chemokines | |||||
 CCL2 (MCP-1) | 31 | .64 (.35–.81) | .0002 | 0 | na |
 CCL3 (MIP-1α) |  |  |  | 58 | 9/13 (69%) |
 CCL4 (MIP-1β) |  |  |  | 48 | 12/12 (100%) |
 CCL7 (MCP-3) |  |  |  | 71 | 12/19 (63%) |
 CCL11 (EOTAXIN) |  |  |  | 97 | 26/30 (87%) |
 CCL22 (MDC) |  |  |  | 32 | 5/10 (50%) |
 CXCL1 (GRO) | 29 | .53 (.18–.75) | .004 | 6 | 0/2 (0%) |
 CXCL8 (IL-8) | 31 | .51 (.17–.74) | .004 | 0 | na |
 CXCL10 (IP-10) | 31 | .50 (.16–.73) | .01 | 0 | na |
 CX3CL1 (FRACTALKINE) | 31 | .42 (.06–.68) | .02 | 0 | na |